Splenic marginal zone lymphoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Splenic marginal zone lymphoma}} | {{Splenic marginal zone lymphoma}} | ||
{{CMG}}, {{AE}} {{AS}} | |||
==Overview== | |||
The predominant therapy for splenic marginal zone lymphoma is [[surgery]]. Adjunctive [[radiotherapy]], [[chemotherapy]], and [[biological therapy]] may be required. | |||
==Surgery== | |||
==References== | ==References== |
Revision as of 14:24, 14 January 2016
Splenic marginal zone lymphoma Microchapters |
Differentiating Splenic marginal zone lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Splenic marginal zone lymphoma surgery On the Web |
American Roentgen Ray Society Images of Splenic marginal zone lymphoma surgery |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Risk calculators and risk factors for Splenic marginal zone lymphoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The predominant therapy for splenic marginal zone lymphoma is surgery. Adjunctive radiotherapy, chemotherapy, and biological therapy may be required.